|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/12/15 Larimar Therapeutics, Inc. S-1 1/09/15 77:7.7M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: S-1 Registration Statement (General Form) HTML 1.53M
2: EX-10.3(B) Material Contract HTML 26K
3: EX-10.4 Material Contract HTML 48K
5: EX-23.1 Consent of Experts or Counsel HTML 21K
4: EX-16.1 Letter re: Change in Certifying Accountant HTML 21K
53: R1 Document and Entity Information HTML 36K
42: R2 Consolidated Balance Sheets HTML 108K
51: R3 Consolidated Balance Sheets (Parenthetical) HTML 70K
55: R4 Consolidated Statements of Operations and HTML 77K
Comprehensive Loss
71: R5 Consolidated Statements of Redeemable Convertible HTML 119K
Preferred Stock and Stockholders' Deficit
44: R6 Consolidated Statements of Redeemable Convertible HTML 39K
Preferred Stock and Stockholders' Deficit
(Parenthetical)
50: R7 Consolidated Statements of Cash Flows HTML 139K
38: R8 Nature of the Business and Basis of Presentation HTML 41K
28: R9 Summary of Significant Accounting Policies HTML 98K
72: R10 Property and Equipment, net HTML 32K
57: R11 Accrued Expenses HTML 36K
56: R12 Convertible Promissory Notes HTML 38K
62: R13 Redeemable Convertible Preferred Stock HTML 57K
63: R14 Common Stock HTML 38K
60: R15 Stock-Based Awards HTML 85K
64: R16 Net Loss Per Share HTML 42K
52: R17 Commitments and Contingencies HTML 47K
54: R18 Income Taxes HTML 59K
59: R19 Retirement Plan HTML 29K
77: R20 Australia Research and Development Tax Incentive HTML 32K
67: R21 Related Party Transactions HTML 28K
47: R22 Subsequent Events HTML 27K
58: R23 Summary of Significant Accounting Policies HTML 137K
(Policies)
49: R24 Property and Equipment, net (Tables) HTML 31K
21: R25 Accrued Expenses (Tables) HTML 35K
68: R26 Redeemable Convertible Preferred Stock (Tables) HTML 43K
74: R27 Stock-Based Awards (Tables) HTML 74K
33: R28 Net Loss Per Share (Tables) HTML 46K
32: R29 Commitments and Contingencies (Tables) HTML 38K
36: R30 Income Taxes (Tables) HTML 56K
37: R31 Convertible Promissory Notes (Tables) HTML 28K
39: R32 Nature of the Business and Basis of Presentation - HTML 46K
Additional Information (Detail)
18: R33 Summary of Significant Accounting Policies - HTML 42K
Additional Information (Detail)
65: R34 Schedule of Property and Equipment, Net (Detail) HTML 40K
46: R35 Property and Equipment, net - Additional HTML 26K
Information (Detail)
48: R36 Accrued Expenses - Schedule of Accrued Expenses HTML 45K
(Detail)
24: R37 Convertible Promissory Notes - Additional HTML 63K
Information (Detail)
76: R38 Redeemable Convertible Preferred Stock - HTML 135K
Additional Information (Detail)
12: R39 Schedule of Redeemable Preferred Stock (Detail) HTML 101K
40: R40 Common Stock - Additional Information (Detail) HTML 44K
70: R41 Stock-Based Awards - Additional Information HTML 125K
(Detail)
23: R42 Assumptions used to Determine Fair Value of Stock HTML 36K
Options Granted (Detail)
31: R43 Summary of Stock Options Activity (Detail) HTML 91K
35: R44 Summary of Restricted Stock Activity (Detail) HTML 58K
43: R45 Stock-Based Awards - Summary of Stock-Based HTML 38K
Compensation Expense Related to Stock Options and
Restricted Common Stock (Detail)
17: R46 Computation of Basic and Diluted Earnings Per HTML 45K
Share (Detail)
27: R47 Summary of Common Stock Equivalents Outstanding HTML 39K
(Detail)
14: R48 Commitments and Contingencies - Additional HTML 64K
Information (Detail)
69: R49 Commitments and Contingencies - Schedule of Future HTML 41K
Minimum Lease Payments for Operating Leases
(Detail)
22: R50 Research and Development Expenses Related to HTML 26K
License Agreements (Detail)
66: R51 Income Taxes - Additional Information (Detail) HTML 53K
25: R52 Reconciliation of Federal Statutory Income Tax HTML 59K
Rate (Detail)
41: R53 Schedule of Net Deferred tax Assets (Detail) HTML 69K
13: R54 Summary of Changes in the Valuation Allowance for HTML 32K
Deferred Tax Assets (Detail)
16: R55 Retirement Plan - Additional Information (Detail) HTML 29K
34: R56 Australia Research and Development Tax Incentive - HTML 47K
Additional Information (Detail)
20: R57 Related Party Transactions - Additional HTML 29K
Information (Detail)
73: R58 Subsequent Events - Additional Information HTML 56K
(Detail)
45: R59 Summary of Significant Accounting Policies - HTML 38K
Summary of Common Stock Equivalents Outstanding
(Detail)
61: R60 Notes Payable - Additional Information (Detail) HTML 92K
26: R61 Notes Payable - Schedule of Estimated Future HTML 39K
Principal Payments Due under Term Loan (Detail)
29: R62 Stockholders' Equity - Additional Information HTML 66K
(Detail)
75: XML IDEA XML File -- Filing Summary XML 116K
15: EXCEL IDEA Workbook of Financial Reports XLSX 176K
30: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 826K
6: EX-101.INS XBRL Instance -- zfgn-20140930 XML 1.24M
8: EX-101.CAL XBRL Calculations -- zfgn-20140930_cal XML 182K
9: EX-101.DEF XBRL Definitions -- zfgn-20140930_def XML 489K
10: EX-101.LAB XBRL Labels -- zfgn-20140930_lab XML 1.14M
11: EX-101.PRE XBRL Presentations -- zfgn-20140930_pre XML 838K
7: EX-101.SCH XBRL Schema -- zfgn-20140930 XSD 153K
19: ZIP XBRL Zipped Folder -- 0001193125-15-006755-xbrl Zip 165K
| EX16.1 |
Exhibit 16.1
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Zafgen, Inc. under the heading “Change in Accounting Firm Relationships”, in this registration statement on Form S-1 and we agree with the statements concerning our Firm under that heading.
Very truly yours,
1
| This ‘S-1’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 1/12/15 | 4, 8-K | ||
| Filed on: | 1/9/15 | |||
| 1/8/15 | 4 | |||
| List all Filings | ||||